In order to offer high quality Lubiprostone Intermediate CAS 50889-48-0, we adopt excellent quality ingredients and ultra-modern tool&technology. The Intermediate of Lubiprostone 50889-48-0 product is used for the treatment of chronic hepatitis C in adult patients with compensated liver disease. We can mass production the Lubiprostone Intermediate CAS NO 50889-48-0 and provide various of packaging to meet clients requirement.
Thera. Category: The management of chronic idiopathic constipation
Cas No.: 50889-48-0
Synonym: (3AR,4R,5R,6aS)-4-((E)-4,4-Difluoro-3-oxooct-1-en-1-yl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl;2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)-4-[(1E)-4,4-difluoro-3-oxo-1-octen-1-yl]hexahydro-, (3aR,4R,5R,6aS)-;2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)-4-(4,4-difluoro-3-oxo-1-octenyl)hexahydro-, [3aR-[3aa,4a(E),5b,6aa]]-
Molecular Formula: C22H24F2O5
Molecular Weight: 406.4197664
Assay: ≥99.%
Packing: Export worthy packing
lMaterial Safety Data Sheet: Available on request
Usage: Intermediate of Lubiprostone
Relation Product:
CAS 50889-46-8, Dimethyl (3,3-difluoro-2-oxoheptyl)phosphonate
CAS 50889-48-0, (3AR,4R,5R,6aS)-4-((E)-4,4-Difluoro-3-oxooct-1-en-1-yl)-2-ox